Rapport Therapeutics target price cut to $50 from $51 by Wells Fargo
RAPP•Wells Fargo cut its target price for Rapport Therapeutics to $50 from $51.
Related News
Fort Technology's Logia USA signs exclusive fuel maintenance distribution deal with SVL
NEXR•
France's Macron vows no repeat of riots as Yellow Vests mobilise
TLT•
Disc Medicine falls after $450 million equity raise following rare disease drug trial success
IRON•
Aptiv expands NVIDIA collaboration to lower automated-driving costs
NVDA•
Infineon expands NVIDIA collaboration on 800-volt power systems for AI data centers
NVDA•